Louisiana State Employees Retirement System Makes New Investment in The Cooper Companies, Inc. $COO

Louisiana State Employees Retirement System acquired a new position in The Cooper Companies, Inc. (NASDAQ:COO) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 10,000 shares of the medical device company’s stock, valued at approximately $715,000.

A number of other institutional investors have also added to or reduced their stakes in the business. JANA Partners Management LP purchased a new stake in shares of Cooper Companies during the third quarter valued at about $166,917,000. Alecta Tjanstepension Omsesidigt increased its holdings in shares of Cooper Companies by 15.8% in the third quarter. Alecta Tjanstepension Omsesidigt now owns 1,563,000 shares of the medical device company’s stock valued at $107,112,000 after purchasing an additional 213,500 shares during the period. DAVENPORT & Co LLC increased its holdings in Cooper Companies by 1,359.7% in the 4th quarter. DAVENPORT & Co LLC now owns 567,203 shares of the medical device company’s stock worth $46,642,000 after buying an additional 528,346 shares during the period. Swiss Life Asset Management Ltd lifted its position in Cooper Companies by 63.9% during the third quarter. Swiss Life Asset Management Ltd now owns 49,409 shares of the medical device company’s stock valued at $3,387,000 after purchasing an additional 19,264 shares during the period. Finally, Fluent Financial LLC purchased a new stake in shares of Cooper Companies in the fourth quarter worth about $3,517,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Price Performance

COO stock traded up $0.32 during midday trading on Tuesday, reaching $72.93. The stock had a trading volume of 61,667 shares, compared to its average volume of 2,455,996. The Cooper Companies, Inc. has a 52-week low of $58.89 and a 52-week high of $89.83. The company has a current ratio of 1.27, a quick ratio of 0.78 and a debt-to-equity ratio of 0.23. The company’s fifty day simple moving average is $64.66 and its 200 day simple moving average is $73.26. The company has a market cap of $14.22 billion, a price-to-earnings ratio of 61.81, a price-to-earnings-growth ratio of 1.94 and a beta of 0.84.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, beating analysts’ consensus estimates of $1.10 by $0.11. The business had revenue of $1.08 billion during the quarter, compared to analysts’ expectations of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The company’s quarterly revenue was up 7.9% compared to the same quarter last year. During the same period in the prior year, the business earned $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. As a group, sell-side analysts predict that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on the company. KeyCorp reiterated a “sector weight” rating on shares of Cooper Companies in a research report on Friday, June 5th. The Goldman Sachs Group set a $61.00 target price on Cooper Companies in a research report on Wednesday, May 27th. Stifel Nicolaus reduced their price target on Cooper Companies from $95.00 to $85.00 and set a “buy” rating for the company in a report on Friday, June 5th. Citigroup restated a “neutral” rating and issued a $69.00 price objective (down from $80.00) on shares of Cooper Companies in a research report on Thursday, May 28th. Finally, JPMorgan Chase & Co. cut their price target on shares of Cooper Companies from $80.00 to $71.00 and set a “neutral” rating for the company in a report on Friday, June 5th. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have issued a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $81.31.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.